TITLE

DIETARY SULPHITE AND DISEASE ACTIVITY IN ULCERATIVE COLITIS PATIENTS

AUTHOR(S)
Magee, E. A.; Tasker, S. M.; Edmond, L. M.; Kong, S. C.; Cummings, J. H.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The cause of ulcerative colitis (UC) is unknown, although the relapsing nature and geographical incidence of the disease implicate environmental factors. Sulphiting agents are widely used food additives. Due to the toxicity of sulphur compounds, intakes of sulphited foods are a possible cause of relapse in UC. Intakes of sulphited foods were associated with increased disease activity in UC. The dietary analysis method used provides a new tool for establishing relationships between diet and disease and a potentially therapeutic diet for UC.
ACCESSION #
13218832

 

Related Articles

  • MANAGEMENT OF SPASTIC, IRRITABLE COLON, WITH A NOTE ON ULCERATIVE COLITIS. Rosenblum, Louis A. // American Journal of Gastroenterology;Apr1958, Vol. 29 Issue 4, p407 

    Studies the management of spastic, irritable colon with emphasis on ulcerative colitis. Material and methods; Use of a preparation containing scopolamine methyl bromide, guar gum and a fecal softener; Interpretation of the findings.

  • Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis. Sandborn, William J.; Ghosh, Subrata; Panes, Julian; Vranic, Ivana; Su, Chinyu; Rousell, Samantha; Niezychowski, Wojciech // New England Journal of Medicine;8/16/2012, Vol. 367 Issue 7, p616 

    Background: Ulcerative colitis is a chronic inflammatory disease of the colon for which current treatments are not universally effective. One additional treatment may be tofacitinib (CP-690,550), an oral inhibitor of Janus kinases 1, 2, and 3 with in vitro functional specificity for kinases 1...

  • THE USE OF CORTICOTROPIN-ZINC HYDROXIDE IN THE TREATMENT OF ULCERATIVE COLITIS AND OTHER COLONIC DISORDERS. Riese, Jacob A. // American Journal of Gastroenterology;Oct1957, Vol. 28 Issue 4, p452 

    1. The specific etiology of ulcerative colitis remains unknown. Infection and emotion remain prime etiologic theories. 2. The disease is reviewed with regard to pathology, symptomatology, and differential diagnosis. 3. Treatment of ulcerative colitis and other functional colonic disorders with...

  • EXPRESSION OF LECTINS IN NONSPECIFIC ULCERATIVE COLITIS. Markova, A. A.; Kashkina, E. I.; Maslyakova, G. N. // Saratov Journal of Medical Scientific Research / Saratovskii Nau;Oct-Dec2012, Vol. 8 Issue 4, p937 

    Purpose: To analyze the expression of lectins in mucosa of a colon in patients with ulcerative colitis (UC), depending on the duration, severity, location and activity of the inflammatory process. Materials and methods: A total of 48 patients with ulcerative colitis and 15 healthy people have...

  • The role of Asacol in the treatment of patients with ulcerative colitis. Hall, Alex // Gastrointestinal Nursing;Jun2008, Vol. 6 Issue 5, p8 

    Ulcerative colitis (UC) is a chronic inflammatory bowel disease, which typically presents with faecal urgency, diarrhoea (frequently occurring at night and after meals), blood and mucus in stool, and abdominal pain. Initially, UC involves the rectum and spreads proximally in a pattern to involve...

  • Epidemiologic study of 80 Patients with Ulcerative Colitis refereed to Imam Hospital in Ardabil City during 2004-2010. Amani, Firouz; Sadeghi Movahed, Vahid; Tabarraie, Yaser // Advances in Bioresearch;Mar2014, Vol. 5 Issue 1, p131 

    Ulcerative colitis is one of the inflammatory bowel diseases with unknown etiology. Genetic and environmental factors are thought to be effective in this disease. The aim of this study is to assessment of demographic features and clinical symptoms of Ulcerative colitis patients refereed to Emam...

  • Atypical Rectal Bleeding: The Challenge of Diagnosing Mild Ulcerative Colitis. Levesque, Barrett G.; Pai, Reetesh; Shah, Shamita B. // Digestive Diseases & Sciences;Mar2010, Vol. 55 Issue 3, p586 

    The article presents a case study related to the diagnosis and treatment of mild ulcerative colitis. A 27-year-old developmentally delayed man presented to Stanford University Medical Center for evaluation of rectal bleeding. He reported one to two formed non-bloody bowel movements per day...

  • LONG TERM FOLLOW UP OF UC PATIENTS TREATED WITH CYCLOSPORWI--7 YEAR EXPERIENCE. Campbell, S.; Jewell, D. P. // Gut;Apr2004 Supplement 3, Vol. 53, pA1 

    Cyclosporin (CyA) Rx has emerged as an important agent for rescue Rx in acute severe ulcerative colitis. High 1 year relapse rates advocate a limited role of this treatment in light of CyAs s/e profile. Some advocate CyA only as a stopgap to surgical Rx. There are few data available on longer...

  • Neutrophil-related immunoinflammatory disturbance in steroid-overdosed ulcerative colitis patients. Yoshiyama, Shigeyuki; Miki, Chikao; Okita, Yoshiki; Araki, Toshimitsu; Uchida, Keiichi; Kusunoki, Masato // Journal of Gastroenterology;2008, Vol. 43 Issue 10, p789 

    There is some evidence that large preoperative doses of steroids are a causative factor for postoperative higher morbidity in ulcerative colitis (UC) patients. This study aimed to assess steroid-related changes in functional profiles of neutrophils in UC patients to estimate the immunological...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics